Volume 24, Issue 1 (March 2020)                   Physiol Pharmacol 2020, 24(1): 63-73 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zadehdarvish F, Kesmati M, Khajehpour L, Torabi M. Effects of magnesium oxide nanoparticles on memory impairment induced by postpartum depression model. Physiol Pharmacol 2020; 24 (1) :63-73
URL: http://ppj.phypha.ir/article-1-1514-en.html
Abstract:   (2407 Views)
Introduction: Plasma magnesium level is reduced after postpartum depression in female and this reduction can cause memory impairment. As regards the magnesium has antidepressant activity and it's deficiency leads to depression, the aim of this study was evaluating the effect of magnesium in form of magnesium oxide nanoparticles (MgO NPs) on memory retrieval in a postpartum depression model. Methods: Adult female mice (27±3g) were divided into groups of control, depressed and depressed recipient of MgO NPs (1, 2.5, 5 or 10mg/kg) as an acute and chronic administrations. For induction of postpartum depression, chronic administration (5 days) of progesterone was used and three days after stopping administration, the depressive behavior was evaluated by tail suspension test. Passive avoidance memory and locomotor activity have done 24 hours after training using the step-down and open field devices, respectively. Results: Induction of postpartum depression model by the withdrawal of progesterone significantly decreased the memory retrieval. Acute administration of MgO NP significantly improved depression and memory impairment in a dose-dependent manner, while chronic administration showed less improvement in depression and memory. There was no difference between locomotor activities in all groups. Conclusion: It seems that acute administration of MgO NPs could be more suitable supplement than its chronic ones for improving depression and prevent memory impairment induced by postpartum depression. Probably the duration of nanoparticles administration can be a determining factor in their efficacy.
Full-Text [PDF 909 kb]   (884 Downloads)    

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.